Filing Flows › Dolby Laboratories (DLB) › Q2 FY26 › vs Q2 FY25
Dolby Laboratories (DLB) Q2 FY26 vs Q2 FY25 (year over year)
Dolby Laboratories's revenue rose $26.1M (+7%) from $370M in Q2 FY25 to $396M in Q2 FY26. The biggest changes: Licensing +$26.2M (+8%); Products and services −$170K (-0.7%). Gross margin 88.7% against 90.3% (-1.6 pts).
Dolby Laboratories, Q2 FY26: revenue $396M (+7% year over year), operating margin 28.5%, net earnings $94.9M, operating cash flow $92.5M. The chart draws each line against Q2 FY25, the increases inside each band.
Margins
| Q2 FY26 | Q2 FY25 | Change | |
|---|---|---|---|
| Gross margin | 88.7% | 90.3% | -1.6 pts |
| Operating margin | 28.5% | 29.2% | -0.6 pts |
| Net margin | 24.0% | 24.8% | -0.8 pts |
| Free cash flow margin | 21.1% | 45.5% | -24.4 pts |
Every line
| Line | Q2 FY26 | Q2 FY25 | Change | % |
|---|---|---|---|---|
| Broadcast | $119M | $94.2M | $24.9M | +26% |
| Mobile | $94.2M | $100M | −$5.9M | -6% |
| PC | $59.5M | $58.4M | $1.1M | +2% |
| Other | $58.4M | $55.1M | $3.3M | +6% |
| CE | $40.9M | $38.1M | $2.8M | +7% |
| Licensing | $372M | $346M | $26.2M | +8% |
| Products and services | $23.4M | $23.6M | −$170K | -0.7% |
| Revenue | $396M | $370M | $26.1M | +7% |
| Gross profit | $351M | $334M | $17.2M | +5% |
| Cost of revenue | $44.7M | $35.8M | $8.9M | +25% |
| Other income, net | $6.8M | $12.5M | −$5.7M | -46% |
| Operating profit | $113M | $108M | $5.2M | +5% |
| Operating expenses | $238M | $226M | $12.0M | +5% |
| Pre-tax earnings | $120M | $120M | −$551K | -0.5% |
| Research & development | $63.7M | $61.7M | $1.9M | +3% |
| Sales & marketing | $96.2M | $89.6M | $6.5M | +7% |
| General & admin | $76.0M | $70.4M | $5.5M | +8% |
| Other operating costs | $2.2M | $4.2M | −$2.0M | -48% |
| Net earnings | $94.9M | $91.8M | $3.1M | +3% |
| Minority interests | $539K | $433K | $106K | +24% |
| Income tax | $24.2M | $28.0M | −$3.8M | -13% |
| Depreciation & amortization | $24.1M | $21.5M | $2.6M | +12% |
| Share-based compensation | $30.7M | $30.7M | $44K | +0.1% |
| Working capital & other | $57.2M | −$30.9M | $88.1M | — |
| Operating cash flow | $92.5M | $175M | −$82.4M | -47% |
| Free cash flow (OCF − capex) | $83.4M | $168M | −$84.6M | -50% |
| Capital expenditures | $9.1M | $6.9M | $2.2M | +31% |
Questions
How much did Dolby Laboratories's revenue grow year over year in Q2 FY26?
Dolby Laboratories's revenue rose $26.1M (+7%) from $370M in Q2 FY25 to $396M in Q2 FY26.
What drove Dolby Laboratories's revenue change in Q2 FY26?
Licensing +$26.2M (+8%); Products and services −$170K (-0.7%).